Search Results

11 items found for "Olav Larsen"

Posts (5)

Orion Shares New Data on its Latest Best-in-Class Drug Candidate
Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting
📰 GPCR Weekly News, March 20 to 26, 2023
Oliver Hartley. Below is your Classified GPCR News at a glance for March 20th to 26th, 2023.
📰 GPCR Weekly News, September 11 to 17, 2023
Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr. Ben Myers and Dr.

Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
Authors Olav Larsen , Sara Schuermans , Anna Walser , Stavroula Louka , Ida Aaberg Lillethorup , Jon
Ep 91 with Dr. Oliver Hartley
Oliver Hartley About Dr. Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.
Ep 103 with Dr Kathleen Caron
Oliver Smithies at UNC-CH, where she was the first to discover the essential role of adrenomedullin peptide